The FDA Just Approved a New Topical Treatment for Acne

Curated via Twitter from Allure’s twitter account….

The acne treatment is expected to be available at the beginning of 2021. "Other commonly used acne medications include topical antibiotics and topical retinoids, but Winlevi, also called Clascoterone Cream 1%, is different in that it is the only topical medication that targets the androgen receptors in the skin," says board-certified dermatologist and founder of Eternal Dermatology, Ife Rodney. "The result is less sebum production and oil buildup," she adds.

The most common side effect, which occurred in 7 to 12 percent of patients, was mild erythema — aka reddening of the skin. (Other potential side effects include burning, itching, and peeling. "As with other topical acne medications, [Winlevi] may cause redness, dryness, and irritation of the skin," confirms Rodney. "You should also be careful to not apply it to very large areas of the skin or for long periods of time, as this may increase the risk of internal side effects, like hormonal imbalance," she warns.

Link to original article….

Related videos from YouTube

Leave a Comment

Your email address will not be published. Required fields are marked *